Ipsen and Genfit to file for EMA and FDA approval for elafibranor

Ipsen and Genfit to file for EMA and FDA approval for elafibranor

Submitted by admin on June 30, 2023 - 10:12am
Source: 
Clinical Trials Arena
News Tags: 
Ipsen
Genfit
EMA
FDA
elafibranor
liver disease
primary biliary cholangitis
Headline: 
Ipsen and Genfit to file for EMA and FDA approval for elafibranor
snippet: 

The companies are to file for FDA and EMA approval following positive Phase III results for Elafibranor in rare liver disease.

Do Not Allow Advertisers to Use My Personal information